| Literature DB >> 26334878 |
M Isabel Ordiz1, Thaddaeus D May2, Kathie Mihindukulasuriya3, John Martin3, Jan Crowley4, Phillip I Tarr1, Kelsey Ryan1, Elissa Mortimer5, Geetha Gopalsamy5, Ken Maleta6, Makedonka Mitreva3,7, Graeme Young5, Mark J Manary8,9,10,11.
Abstract
BACKGROUND: Resistant starch (RS) decreases intestinal inflammation in some settings. We tested the hypothesis that gut inflammation will be reduced with dietary supplementation with RS in rural Malawian children. Eighteen stunted 3-5-year-old children were supplemented with 8.5 g/day of RS type 2 for 4 weeks. The fecal samples were analyzed for the microbiota, the microbiome, short chain fatty acids, metabolome, and proteins indicative of inflammation before and after the intervention. Subjects served as their own controls.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26334878 PMCID: PMC4558878 DOI: 10.1186/s40168-015-0102-9
Source DB: PubMed Journal: Microbiome ISSN: 2049-2618 Impact factor: 14.650
Fig. 116S RNA bacterial sequences represent in fecal samples from 18 Malawian children before and after adding RS to their diet. Pie charts of average values of relative abundance (percentage of sequences) of the most abundant bacterial groups: phyla (a), and genus (b) found in the fecal microbiota
Listing of all bacterial classifications that exhibited changes in the intervention
| Habitual diet | Habitual diet + RS |
| |
|---|---|---|---|
| Phylum | |||
|
| 50.5 ± 14.2 | 57.6 ± 11.9 | 0.05 |
|
| 47.2 ± 13.4 | 39.0 ± 11.6 | 0.03 |
|
| 0.2 ± 0.1 | 0.7 ± 1.2 | <0.001 |
| Class | |||
|
| 50.6 ± 14.2 | 57.7 ± 11.9 | 0.03 |
|
| 42.4 ± 13.5 | 31.7 ± 9.2 | <0.001 |
|
| 2.3 ± 3.2 | 4.3 ± 4.3 | 0.04 |
|
| 0.2 ± 0.1 | 0.7 ± 1.2 | 0.01 |
|
| 0.1 ± 0.1 | 0.08 ± 0.08 | 0.02 |
| Order | |||
|
| 50.7 ± 14.2 | 57.8 ± 11.9 | 0.05 |
|
| 42.5 ± 13.5 | 31.7 ± 9.2 | <0.001 |
|
| 2.3 ± 3.2 | 4.3 ± 4.3 | 0.01 |
|
| 0.1 ± 0.1 | 0.7 ± 1.2 | <0.001 |
|
| 0.1 ± 0.2 | 0.0 ± 0.2 | 0.04 |
|
| 0.1 ± 0.3 | 0.8 ± 2.3 | 0.01 |
|
| 0.1 ± 0.1 | 0.1 ± 0.2 | 0.04 |
|
| 0.0 ± 0.1 | 0.0 ± 0.0 | 0.03 |
|
| 0.02 ± 0.04 | 0.0 ± 0.01 | 0.02 |
| Family | |||
|
| 21.4 ± 7.4 | 12.2 ± 5.3 | <0.001 |
|
| 1.2 ± 2.3 | 0.7 ± 1.5 | 0.04 |
|
| 0.7 ± 0.7 | 1.2 ± 1.1 | 0.05 |
|
| 0.6 ± 0.6 | 0.4 ± 0.6 | 0.03 |
|
| 0.5 ± 0.3 | 0.2 ± 0.1 | <0.001 |
|
| 0.2 ± 0.3 | 1.4 ± 2.6 | 0.04 |
|
| 0.1 ± 0.1 | 0.7 ± 1.2 | <0.001 |
|
| 0.1 ± 0.1 | 0.06 ± 0.10 | 0.01 |
|
| 0.1 ± 0.2 | 0.0 ± 0.2 | 0.04 |
|
| 0.1 ± 0.3 | 0.8 ± 2.3 | 0.01 |
|
| 0.1 ± 0.2 | 0.0 ± 0.2 | 0.04 |
| Genus | |||
|
| 5.7 ± 2.9 | 3.5 ± 2.2 | <0.001 |
|
| 4.8 ± 3.2 | 2.6 ± 1.9 | <0.001 |
|
| 4.6 ± 2.1 | 2.2 ± 1.2 | <0.001 |
|
| 3.5 ± 2.0 | 2.2 ± 1.6 | 0.03 |
|
| 1.2 ± 2.3 | 0.7 ± 1.5 | 0.04 |
|
| 1.1 ± 0.8 | 0.6 ± 0.5 | <0.001 |
|
| 0.7 ± 0.5 | 0.3 ± 0.2 | <0.001 |
| Oscillibacter | 0.6 ± 0.9 | 0.3 ± 0.4 | <0.001 |
|
| 0.5 ± 0.3 | 0.3 ± 0.2 | <0.001 |
|
| 0.5 ± 0.7 | 0.3 ± 0.6 | 0.03 |
|
| 0.4 ± 0.6 | 0.3 ± 0.4 | 0.02 |
| Catenibacterium | 0.3 ± 0.5 | 0.7 ± 1.0 | 0.01 |
|
| 0.2 ± 0.3 | 1.4 ± 2.6 | 0.04 |
The table shows the average values of relative abundance (percentage of sequences using both pairs) after adding resistant starch (RS) to the habitual diet of rural Malawian children. Values expressed as mean ± SD; P value determined by Wilcoxon Signed Ranks test
Fig. 2LEfse rank plot of differentially abundant pathways in gut microbiomes initial vs. final samples. LDA scores were given for different abundance of pathways before (habitual diet: green) and after the resistant starch was added to the habitual diet (habitual diet + RS: red)
SCFA and metabolites with differential expression in fecal samples of 18 Malawian children fed with RS
| Habitual diet | Habitual diet + RS |
| |
|---|---|---|---|
| SCFA (μmol/g) | |||
| Total short-chain fatty acids | 38.0 ± 8.6 | 35.9 ± 9.7 | 0.557 |
| Acetate | 23.0 ± 6.4 | 17.8 ± 6.6 | 0.003* |
| Propionate | 6.5 ± 2.1 | 8.5 ± 3.0 | 0.007* |
| Butyrate | 8.5 ± 2.6 | 9.7 ± 4.1 | 0.306 |
| Mean ratio | 95 % CI | ||
| Metabolite | |||
| 3,4-Di-hydroxy-butanoate | 4.3 | [2.6, 5.9] | |
| β-Alanine | 5.5 | [1.7, 9.3] | |
| 2-Hydroxy-butyrate | 8.4 | [3.6, 13.2] | |
| Malate | 70 | [1.9, 139] | |
| Citramalate | 41 | [15, 67] | |
| Phenylacetate | 5.1 | [2.0, 8.3] | |
Values expressed as mean ± SD; P value determined by Wilcoxon Signed Ranks test. The metabolites are expressed as average of the ratio of concentration in stool after RS versus before RS administration for each child
CI confidence interval
*Significant difference p < 0.05
Determination of human mRNAs in fecal samples from Malawian children before and after addition of RS
| Transcript | Habitual diet | Habitual diet + RS |
|
|---|---|---|---|
| Caudal type homeobox 1 | 0.03 ± 0.01 | 0.03 ± 0.01 | 0.424 |
| CKLF-like MARVEL transmembrane domain containing 6 | 0.02 ± 0.01 | 0.07 ± 0.09 | 0.182 |
| Family with sequence similarity 65, member B | 0.01 ± 0.01 | 0.02 ± 0.03 | 0.779 |
| Major histocompatibility complex, class II, DR alpha | 0.29 ± 0.17 | 0.25 ± 0.14 | 0.332 |
| Interleukin-1β | 0.67 ± 0.73 | 3.56 ± 6.89 | 0.053 |
| Interleukin-8 | 0.93 ± 0.96 | 2.03 ± 2.90 | 0.231 |
| S100 calcium-binding protein A8 (calprotectin) | 0.24 ± 0.24 | 1.22 ± 1.84 | 0.006 |
| Sucrose isomaltase | 0.01 ± 0.01 | 0.02 ± 0.02 | 0.424 |
| Mitochondrial superoxide dismutase 2 | 0.65 ± 0.46 | 1.28 ± 1.25 | 0.575 |
| Toll-like receptor-4 | 0.02 ± 0.01 | 0.09 + 0.11 | 0.062 |
The ratio of transcript: GAPDH are reported. Values expressed as mean ± SD; p value were determined by Wilcoxon signed ranks test